Bullous impetigo

Blisters appear as fluid-filled sacs on the skin, often starting as small vesicles that enlarge over time. They are caused by the production of exfoliative toxins by Staphylococcus aureus, which cleave desmoglein-1, a protein that holds skin cells together. Over time, these blisters may rupture, leading to crusted lesions. The presence of blisters can cause discomfort and pain, and maintaining skin hygiene is crucial to prevent secondary infections.

Redness, or erythema, manifests as an inflamed, red area surrounding the blisters. This occurs due to increased blood flow to the affected area as part of the body's inflammatory response to infection. As the condition progresses, the redness may spread or intensify, especially if the blisters rupture. Redness can cause itching or irritation, and topical treatments may be used to soothe the skin.

Itching is a common symptom that accompanies the development of blisters and redness. It is triggered by the release of inflammatory mediators and histamines in response to the infection. Over time, persistent itching can lead to scratching, which may exacerbate skin damage and increase the risk of secondary infections. To manage itching, antihistamines or topical anti-itch creams may be recommended.

Crusting occurs when blisters rupture and the fluid dries, forming a yellowish-brown crust on the skin. This is a natural part of the healing process as the body works to repair the damaged skin barrier. Over time, crusting may resolve as new skin forms underneath, but it can be unsightly and cause embarrassment for the patient. Proper wound care and hygiene are important to prevent infection and promote healing.

Pain is often experienced at the site of blisters and can range from mild discomfort to severe pain. It results from the inflammation and damage to the skin layers caused by the bacterial toxins. As the blisters rupture and crust, the pain may persist or worsen due to exposure of raw skin. Pain management may include analgesics or topical anesthetics to improve comfort and quality of life.

Swelling, or edema, can accompany redness and blisters, presenting as puffiness around the affected areas. This occurs due to the accumulation of fluid in the tissues as part of the inflammatory response. Over time, swelling may fluctuate, often increasing with activity or heat exposure. Elevating the affected area and applying cold compresses can help reduce swelling and associated discomfort.

Fever may occur as a systemic response to the bacterial infection, presenting as an elevated body temperature. It is part of the body's immune response to fight off the infection. As the skin condition improves, the fever typically subsides, but persistent fever may indicate a more severe infection. Monitoring temperature and using antipyretics can help manage fever and prevent complications.

Lymphadenopathy, or swollen lymph nodes, can occur as the body's immune system responds to the infection. It is characterized by enlarged, tender lymph nodes near the affected area. Over time, lymphadenopathy may resolve as the infection is controlled, but persistent swelling may require further investigation. Rest and anti-inflammatory medications can help alleviate discomfort associated with swollen lymph nodes.

Clinicians look for superficial blisters that rupture easily, leaving a honey-colored crust, primarily on the face and extremities. A history of recent skin trauma or insect bites may be relevant, as these can predispose to infection. Physical examination reveals non-bullous and bullous lesions, with the latter being more indicative of bullous impetigo. This step helps differentiate impetigo from other blistering skin conditions and guides further diagnostic testing.

Imaging is not typically used in the diagnosis of bullous impetigo, as the condition is primarily diagnosed clinically. However, in atypical cases or when complications are suspected, ultrasound may be used to assess deeper tissue involvement. Imaging findings are generally non-specific but can help exclude other conditions like cellulitis or abscesses. The absence of deep tissue involvement on imaging supports a diagnosis of bullous impetigo over other more invasive infections.

Bacterial culture from the lesion can be ordered to identify Staphylococcus aureus, the common causative agent. The presence of exfoliative toxin-producing strains confirms the diagnosis of bullous impetigo. Abnormal results include positive cultures for S. aureus and possibly elevated white blood cell counts if systemic involvement occurs. These results guide antibiotic selection and help monitor treatment response.

Genetic testing is not typically performed for bullous impetigo, as it is an infectious rather than a genetic condition. However, in rare cases where a genetic predisposition to skin infections is suspected, genes related to immune function may be sequenced. No specific mutations are associated with bullous impetigo, but results can inform about underlying immunodeficiencies. This information can be valuable for family counseling regarding susceptibility to infections.